Dear ZTAS customer,

We are happy and proud to announce that Zaponex® Orodispersible tablets (12.5 mg, 25 mg, 50 mg, 100 mg, 200 mg) have been registered by the MHRA on 29 March 2019. Zaponex® Orodispersible tablets are available from 1 July 2019 and are monitored via the Zaponex Treatment Access System.

The product information (SPC and PIL) is available via the Electronic Medicines Compendium. For additional information please contact us at

Leyden Delta

For registration,
please download forms.